These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 31149530)

  • 1. Severe adverse events due to dihydropyrimidine dehydrogenase deficiency in a Japanese patient with colon cancer taking capecitabine: a case report.
    Tsutsui M; Yamamoto S; Yoshikawa Y; Nakanishi R; Takano K; Osumi K; Akatsu T; Yoneyama K; Nakagawa M; Kanai T
    Int Cancer Conf J; 2018 Oct; 7(4):125-129. PubMed ID: 31149530
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A case report of a severe fluoropyrimidine-related toxicity due to an uncommon DPYD variant.
    De Falco V; Natalicchio MI; Napolitano S; Coppola N; Conzo G; Martinelli E; Zanaletti N; Vitale P; Giunta EF; Vietri MT; Vitiello PP; Ciardiello D; Marinaccio A; De Vita F; Ciardiello F; Troiani T
    Medicine (Baltimore); 2019 May; 98(21):e15759. PubMed ID: 31124962
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Dihydropyrimidine dehydrogenase deficiency causes severe adverse effects of capecitabine].
    Inoue H; Sato Y; Shintani S; Tanabe H; Bamba H; Komai Y; Nakamura T; Imai T; Andou A
    Nihon Shokakibyo Gakkai Zasshi; 2018; 115(3):290-298. PubMed ID: 29526981
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Dihydropyrimidine déhydrogenase (DPD) deficiency screening and securing of fluoropyrimidine-based chemotherapies: Update and recommendations of the French GPCO-Unicancer and RNPGx networks].
    Loriot MA; Ciccolini J; Thomas F; Barin-Le-Guellec C; Royer B; Milano G; Picard N; Becquemont L; Verstuyft C; Narjoz C; Schmitt A; Bobin-Dubigeon C; Harle A; Paci A; Poinsignon V; Quaranta S; Evrard A; Hennart B; Broly F; Fonrose X; Lafay-Chebassier C; Wozny AS; Masskouri F; Boyer JC; Etienne-Grimaldi MC
    Bull Cancer; 2018 Apr; 105(4):397-407. PubMed ID: 29486921
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cytomegalovirus enterocolitis in a patient with dihydropyrimidine dehydrogenase deficiency after capecitabine treatment: A case report.
    Inoue F; Yano T; Nakahara M; Okuda H; Amano H; Yonehara S; Noriyuki T
    Int J Surg Case Rep; 2019; 56():55-58. PubMed ID: 30831507
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Capecitabine-based treatment of a patient with a novel DPYD genotype and complete dihydropyrimidine dehydrogenase deficiency.
    Henricks LM; Siemerink EJM; Rosing H; Meijer J; Goorden SMI; Polstra AM; Zoetekouw L; Cats A; Schellens JHM; van Kuilenburg ABP
    Int J Cancer; 2018 Jan; 142(2):424-430. PubMed ID: 28929491
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Severe toxicity of capecitabine in a patient with DPD deficiency after a safe FEC-100 experience: why we should test DPD deficiency in all patients before high-dose fluoropyrimidines.
    Maillard M; Eche-Gass A; Ung M; Brice A; Marsili S; Montastruc M; Puisset F; Thomas F
    Cancer Chemother Pharmacol; 2021 Apr; 87(4):579-583. PubMed ID: 33587160
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Delayed Presentation of DPD Deficiency in Colorectal Cancer.
    Law L; Rogers J; Eng C
    J Adv Pract Oncol; 2014 May; 5(3):205-10. PubMed ID: 25089219
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Evaluation of Dihydropyrimidine Dehydrogenase Enzyme Level in the Serum of Colorectal Cancer Iraqi Males on Fluoropyrimidine-Based Chemotherapy (Capecitabine).
    Challoob MA; Mohammed NS
    Cureus; 2023 Sep; 15(9):e44534. PubMed ID: 37790008
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [A case in which dihydropyrimidine dehydrogenase deficiency was strongly suspected during adjuvant chemotherapy with capecitabine for colon cancer].
    Toshima T; Kodera M; Yamashita Y; Oishi M; Seshimo K; Yamamura M; Kato H; Ikeda H; Mizuno K
    Gan To Kagaku Ryoho; 2013 Nov; 40(11):1549-52. PubMed ID: 24231713
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Complete DPYD genotyping combined with dihydropyrimidine dehydrogenase phenotyping to prevent fluoropyrimidine toxicity: A retrospective study.
    De Metz C; Hennart B; Aymes E; Cren PY; Martignène N; Penel N; Barthoulot M; Carnot A
    Cancer Med; 2024 Mar; 13(6):e7066. PubMed ID: 38523525
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treating patients with dihydropyrimidine dehydrogenase (DPD) deficiency with fluoropyrimidine chemotherapy since the onset of routine prospective testing-The experience of a large oncology center in the United Kingdom.
    Wang L; Howlett S; Essapen S
    Semin Oncol; 2022 Apr; 49(2):170-177. PubMed ID: 35027218
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Severe Gastrointestinal Disorder Due to Capecitabine Associated with Dihydropyrimidine Dehydrogenase Deficiency: A Case Report and Literature Review.
    Hagiwara Y; Yamamoto Y; Inagaki Y; Tomisaki R; Tsuji M; Fukuda S; Fukuda S; Onoda T; Suzuki H; Niisato Y; Tange Y; Ikeda N; Yamada K; Kobayashi M; Akutsu D; Yamada T; Moriwaki T; Narasaka T; Suzuki H; Tsuchiya K
    Intern Med; 2022 Aug; 61(16):2449-2455. PubMed ID: 35110482
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Dihydropyrimidine dehydrogenase deficiency and toxicity to fluoropyrimidine].
    Boisdron-Celle M; Morel A; Gamelin E
    Ann Biol Clin (Paris); 2010; 68(1):27-32. PubMed ID: 20146975
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Suspected dihydropyrimidine dehydrogenase deficiency in a patient receiving capecitabine as adjuvant chemotherapy after colon resection].
    Nagai K; Okuda Y; Ohara Y; Yamamoto M
    Gan To Kagaku Ryoho; 2015 Jan; 42(1):127-9. PubMed ID: 25596695
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Novel
    Tong CC; Lam CW; Lam KO; Lee VHF; Luk MY
    Front Oncol; 2018; 8():279. PubMed ID: 30087856
    [No Abstract]   [Full Text] [Related]  

  • 17. [A Case of Colon Cancer with Suspected DPD Deficiency Causing Severe Adverse Effects following Adjuvant Chemotherapy with Capecitabine].
    Nagahisa S; Watanabe M; Minagi H; Ogawa T; Araki H; Kimura Y; Taniguchi F; Arata T; Katsuda K; Tanakaya K; Aoki H
    Gan To Kagaku Ryoho; 2021 Dec; 48(13):1928-1931. PubMed ID: 35045450
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Is capecitabine safe in patients with gastrointestinal cancer and dihydropyrimidine dehydrogenase deficiency?
    Saif MW; Diasio R
    Clin Colorectal Cancer; 2006 Jan; 5(5):359-62. PubMed ID: 16512996
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.